Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

577 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Quality Criteria for Real-world Data in Pharmaceutical Research and Health Care Decision-making: Austrian Expert Consensus.
Klimek P, Baltic D, Brunner M, Degelsegger-Marquez A, Garhöfer G, Gouya-Lechner G, Herzog A, Jilma B, Kähler S, Mikl V, Mraz B, Ostermann H, Röhl C, Scharinger R, Stamm T, Strassnig M, Wirthumer-Hoche C, Pleiner-Duxneuner J. Klimek P, et al. Among authors: jilma b. JMIR Med Inform. 2022 Jun 17;10(6):e34204. doi: 10.2196/34204. JMIR Med Inform. 2022. PMID: 35713954 Free PMC article.
Influence of proton pump inhibitors and VKORC1 mutations on CYP2C9-mediated dose requirements of vitamin K antagonist therapy: a pilot study.
Brunner-Ziegler S, Jilma B, Magirr D, Sunder-Plassmann R, Giurgea GA, Hammer A, Margeta C, Brunner M, Koppensteiner R, Mannhalter C. Brunner-Ziegler S, et al. Among authors: jilma b. Br J Haematol. 2014 Nov;167(4):547-53. doi: 10.1111/bjh.13082. Epub 2014 Aug 21. Br J Haematol. 2014. PMID: 25142093 Free article. Clinical Trial.
Comparison between the impact of morning and evening doses of rivaroxaban on the circadian endogenous coagulation rhythm in healthy subjects.
Brunner-Ziegler S, Jilma B, Schörgenhofer C, Winkler F, Jilma-Stohlawetz P, Koppensteiner R, Quehenberger P, Seger C, Weigel G, Griesmacher A, Brunner M. Brunner-Ziegler S, et al. Among authors: jilma b, jilma stohlawetz p. J Thromb Haemost. 2016 Feb;14(2):316-23. doi: 10.1111/jth.13213. Epub 2016 Jan 30. J Thromb Haemost. 2016. PMID: 26644369 Free article. Clinical Trial.
Safety of a universal, virus-inactivated and prion-depleted, pharmaceutical-quality plasma: a randomized, double-blind, clinical trial in healthy volunteers.
Jilma-Stohlawetz P, Kursten FW, Walasek C, Horvath M, Leitner G, List J, Quehenberger P, Schwameis M, Bartko J, Jilma B. Jilma-Stohlawetz P, et al. Among authors: jilma b. Transfusion. 2011 Jun;51(6):1228-40. doi: 10.1111/j.1537-2995.2010.03005.x. Epub 2011 Feb 18. Transfusion. 2011. PMID: 21332722 Clinical Trial.
Recovery, safety, and tolerability of a solvent/detergent-treated and prion-safeguarded transfusion plasma in a randomized, crossover, clinical trial in healthy volunteers.
Jilma-Stohlawetz P, Kursten FW, Horvath M, Leitner G, List J, Marcek J, Quehenberger P, Schwameis M, Bartko J, Derhaschnig U, Jilma B. Jilma-Stohlawetz P, et al. Among authors: jilma b. Transfusion. 2013 Sep;53(9):1906-17. doi: 10.1111/trf.12075. Epub 2013 Jan 16. Transfusion. 2013. PMID: 23320451 Clinical Trial.
577 results